Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer
Clinical trial NCT03727724 · COMPLETED
Trial details
- NCT number
- NCT03727724
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-04
- Primary completion
- 2022-09-06
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.